BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 27661107)

  • 1. RNF43 and ZNRF3 are commonly altered in serrated pathway colorectal tumorigenesis.
    Bond CE; McKeone DM; Kalimutho M; Bettington ML; Pearson SA; Dumenil TD; Wockner LF; Burge M; Leggett BA; Whitehall VL
    Oncotarget; 2016 Oct; 7(43):70589-70600. PubMed ID: 27661107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNF43 germline and somatic mutation in serrated neoplasia pathway and its association with BRAF mutation.
    Yan HHN; Lai JCW; Ho SL; Leung WK; Law WL; Lee JFY; Chan AKW; Tsui WY; Chan ASY; Lee BCH; Yue SSK; Man AHY; Clevers H; Yuen ST; Leung SY
    Gut; 2017 Sep; 66(9):1645-1656. PubMed ID: 27329244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of RNF43 frameshift mutations that drive Wnt ligand- and R-spondin-dependent colon cancer.
    Yamamoto D; Oshima H; Wang D; Takeda H; Kita K; Lei X; Nakayama M; Murakami K; Ohama T; Takemura H; Toyota M; Suzuki H; Inaki N; Oshima M
    J Pathol; 2022 May; 257(1):39-52. PubMed ID: 35040131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNF43 is mutated less frequently in Lynch Syndrome compared with sporadic microsatellite unstable colorectal cancers.
    Fennell LJ; Clendenning M; McKeone DM; Jamieson SH; Balachandran S; Borowsky J; Liu J; Kawamata F; Bond CE; Rosty C; Burge ME; Buchanan DD; Leggett BA; Whitehall VLJ
    Fam Cancer; 2018 Jan; 17(1):63-69. PubMed ID: 28573495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNF43 mutation is associated with aggressive tumor biology along with BRAF V600E mutation in right-sided colorectal cancer.
    Matsumoto A; Shimada Y; Nakano M; Oyanagi H; Tajima Y; Nakano M; Kameyama H; Hirose Y; Ichikawa H; Nagahashi M; Nogami H; Maruyama S; Takii Y; Ling Y; Okuda S; Wakai T
    Oncol Rep; 2020 Jun; 43(6):1853-1862. PubMed ID: 32236609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent frameshift mutations in 2 mononucleotide repeats of RNF43 gene and its regional heterogeneity in gastric and colorectal cancers.
    Jo YS; Kim MS; Lee JH; Lee SH; An CH; Yoo NJ
    Hum Pathol; 2015 Nov; 46(11):1640-6. PubMed ID: 26297255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 mutation is common in microsatellite stable, BRAF mutant colorectal cancers.
    Bond CE; Umapathy A; Ramsnes I; Greco SA; Zhen Zhao Z; Mallitt KA; Buttenshaw RL; Montgomery GW; Leggett BA; Whitehall VL
    Int J Cancer; 2012 Apr; 130(7):1567-76. PubMed ID: 21557216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNF43 Is an Early and Specific Mutated Gene in the Serrated Pathway, With Increased Frequency in Traditional Serrated Adenoma and Its Associated Malignancy.
    Tsai JH; Liau JY; Yuan CT; Lin YL; Tseng LH; Cheng ML; Jeng YM
    Am J Surg Pathol; 2016 Oct; 40(10):1352-9. PubMed ID: 27305845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The most common RNF43 mutant G659Vfs*41 is fully functional in inhibiting Wnt signaling and unlikely to play a role in tumorigenesis.
    Tu J; Park S; Yu W; Zhang S; Wu L; Carmon K; Liu QJ
    Sci Rep; 2019 Dec; 9(1):18557. PubMed ID: 31811196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dishevelled promotes Wnt receptor degradation through recruitment of ZNRF3/RNF43 E3 ubiquitin ligases.
    Jiang X; Charlat O; Zamponi R; Yang Y; Cong F
    Mol Cell; 2015 May; 58(3):522-33. PubMed ID: 25891077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exome sequencing revealed comparable frequencies of RNF43 and BRAF mutations in Middle Eastern colorectal cancer.
    Siraj AK; Bu R; Masoodi T; Parvathareddy SK; Iqbal K; Al-Haqawi W; Al-Dossari H; Azam S; Qadri Z; Annaiyappanaidu P; Al-Dayel F; Al-Kuraya KS
    Sci Rep; 2022 Jul; 12(1):13098. PubMed ID: 35907983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high-level CpG Island methylator phenotype and mismatch repair-deficiency.
    Dawson H; Galván JA; Helbling M; Muller DE; Karamitopoulou E; Koelzer VH; Economou M; Hammer C; Lugli A; Zlobec I
    Int J Cancer; 2014 May; 134(10):2342-51. PubMed ID: 24166180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological and molecular correlations in traditional serrated adenoma.
    Sekine S; Yamashita S; Yamada M; Hashimoto T; Ogawa R; Yoshida H; Taniguchi H; Kojima M; Ushijima T; Saito Y
    J Gastroenterol; 2020 Apr; 55(4):418-427. PubMed ID: 32052185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation and expression of the tumour suppressor, PRDM5, in colorectal cancer and polyp subgroups.
    Bond CE; Bettington ML; Pearson SA; McKeone DM; Leggett BA; Whitehall VL
    BMC Cancer; 2015 Jan; 15():20. PubMed ID: 25613750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of APC in WNT pathway activation in serrated neoplasia.
    Borowsky J; Dumenil T; Bettington M; Pearson SA; Bond C; Fennell L; Liu C; McKeone D; Rosty C; Brown I; Walker N; Leggett B; Whitehall V
    Mod Pathol; 2018 Mar; 31(3):495-504. PubMed ID: 29148535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of RNF43 Genetic Alterations With BRAF
    Vogel A; Murugesan K; Kendre G; Quintanilha JCF; Ross JS; Brummer T; Saborowski A
    JCO Precis Oncol; 2024 Feb; 8():e2300411. PubMed ID: 38394466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNF43 mutation analysis in serrated polyposis, sporadic serrated polyps and Lynch syndrome polyps.
    van Herwaarden YJ; Koggel LM; Simmer F; Vink-Börger EM; Dura P; Meijer GA; Nagengast FM; Hoogerbrugge N; Bisseling TM; Nagtegaal ID
    Histopathology; 2021 Apr; 78(5):749-758. PubMed ID: 33098683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive Analysis of R-Spondin Fusions and RNF43 Mutations Implicate Novel Therapeutic Options in Colorectal Cancer.
    Seeber A; Battaglin F; Zimmer K; Kocher F; Baca Y; Xiu J; Spizzo G; Novotny-Diermayr V; Rieder D; Puccini A; Swensen J; Ellis M; Goldberg RM; Grothey A; Shields AF; Marshall JL; Weinberg BA; Sackstein PE; Lim KH; Tan GS; Nabhan C; Korn WM; Amann A; Trajanoski Z; Berger MD; Lou E; Wolf D; Lenz HJ
    Clin Cancer Res; 2022 May; 28(9):1863-1870. PubMed ID: 35254413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of loss-of-function mutations at the RNF43 locus on colorectal cancer development and progression.
    Eto T; Miyake K; Nosho K; Ohmuraya M; Imamura Y; Arima K; Kanno S; Fu L; Kiyozumi Y; Izumi D; Sugihara H; Hiyoshi Y; Miyamoto Y; Sawayama H; Iwatsuki M; Baba Y; Yoshida N; Furukawa T; Araki K; Baba H; Ishimoto T
    J Pathol; 2018 Aug; 245(4):445-455. PubMed ID: 29756208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of BRAF-V600E in the serrated pathway of colorectal tumourigenesis.
    Minoo P; Moyer MP; Jass JR
    J Pathol; 2007 Jun; 212(2):124-33. PubMed ID: 17427169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.